Showing results (21-30 of 426) with videos related to

Sort By:
Pageof 43
Archives Italiennes De Biologie|March 18, 2011
Future therapeutical strategies dictated by pre-clinical evidence in ALSFrancesco Fornai, Vincent Meininger, Vincent Silani
Presse Medicale (Paris, France : 1983)|May 3, 2014
[What are the applications of biomarkers in ALS today?]Hélène Blasco, Philippe Corcia, Pierre-François Pradat
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|October 12, 2010
The P413L chromogranin B variation in French patients with sporadic amyotrophic lateral sclerosisHélène Blasco, Philippe Corcia, Charlotte Veyrat-Durebex, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 2, 2018
Phenotypic and genotypic studies of ALS cases in ALS-SMA familiesPhilippe Corcia, Patrick Vourc'h, Helene Blasco, et al.
Central Nervous System Agents in Medicinal Chemistry|December 22, 2009
Recent advances in the treatment of amyotrophic lateral sclerosis. Emphasis on kynurenine pathway inhibitorsYiquan Chen, Vincent Meininger, Gilles J Guillemin
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|June 3, 2014
Somatosensory evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathyHayet Salhi, Philippe Corcia, Steve Remer, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 7, 2014
Is there a paraneoplastic ALS?Philippe Corcia, Paul H Gordon, Jean-Philippe Camdessanche
Psychologie & Neuropsychiatrie Du Vieillissement|August 27, 2010
[DEX and executive dysfunction in activities of daily living in Alzheimer's disease and frontotemporal dementia]Ambre Piquard, Christian Derouesné, Vincent Meininger, et al.
Neuro-Degenerative Diseases|August 16, 2006
Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosisGilles J Guillemin, Vincent Meininger, Bruce J Brew
Pageof 43